GE HealthCare Technologies (NASDAQ:GEHC) Issues FY 2026 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 4.950-5.150 for the period, compared to the consensus EPS estimate of 4.930. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on GEHC. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Wells Fargo & Company cut their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, January 7th. Jefferies Financial Group boosted their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, Evercore ISI reiterated an “outperform” rating and issued a $95.00 price objective on shares of GE HealthCare Technologies in a report on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Hold” and a consensus target price of $90.67.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC traded up $4.92 during trading on Wednesday, hitting $83.70. 3,799,404 shares of the company traded hands, compared to its average volume of 3,529,474. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $94.80. The stock has a market capitalization of $38.13 billion, a price-to-earnings ratio of 17.28, a PEG ratio of 2.42 and a beta of 1.08. The business’s fifty day moving average is $82.64 and its 200-day moving average is $77.43. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Quarterly beat — GEHC reported Q4 EPS of $1.44 and revenue of $5.70B, topping consensus and showing 7.1% revenue growth year‑over‑year; this is the primary catalyst supporting the stock’s rise. Read More.
• Positive Sentiment: FY‑2026 guidance slightly above expectations — management set EPS guidance of $4.95–$5.15 vs. consensus ~4.93, signaling continued profitable growth and giving investors confidence in forward results.
• Positive Sentiment: Analyst upgrade/price‑target lift — BTIG raised its price target from $87 to $91 and keeps a Buy rating, adding institutional momentum and perceived upside. Read More.
• Positive Sentiment: Demand tailwinds called out by management — Reuters notes GEHC’s forecast for 2026 profit above estimates on robust demand for diagnostic and imaging devices, reinforcing the growth narrative. Read More.
• Positive Sentiment: Product commercialization progress — FDA and CE clearance for the Allia Moveo (mobile C‑arm with AI guidance) supports future commercialization and revenue mix improvement. Read More.
• Neutral Sentiment: Company materials and call available — Management released the earnings press release, slide deck and hosted a conference call (useful for details on margin plans and capital allocation). Read More.
• Negative Sentiment: Margin pressure — Net margin declined as tariffs and product‑mix shifts weighed on profitability; investors will watch whether mix and cost actions restore margins. Read More.
• Negative Sentiment: Profit down year‑over‑year — Coverage highlights that profit fell despite higher revenue, a reminder that near‑term margins remain a risk factor for the stock. Read More.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of large investors have recently added to or reduced their stakes in the business. Brooklyn Investment Group raised its holdings in GE HealthCare Technologies by 11.9% in the 3rd quarter. Brooklyn Investment Group now owns 3,611 shares of the company’s stock worth $271,000 after purchasing an additional 383 shares during the period. Gamco Investors INC. ET AL raised its holdings in GE HealthCare Technologies by 8.6% during the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock worth $299,000 after purchasing an additional 320 shares in the last quarter. Brown Brothers Harriman & Co. raised its holdings in shares of GE HealthCare Technologies by 4.6% in the third quarter. Brown Brothers Harriman & Co. now owns 4,279 shares of the company’s stock valued at $321,000 after buying an additional 189 shares during the last quarter. State of Wyoming lifted its position in GE HealthCare Technologies by 21.7% in the second quarter. State of Wyoming now owns 4,955 shares of the company’s stock valued at $367,000 after purchasing an additional 885 shares during the period. Finally, Laird Norton Wetherby Wealth Management LLC grew its position in GE HealthCare Technologies by 4.9% during the third quarter. Laird Norton Wetherby Wealth Management LLC now owns 5,131 shares of the company’s stock worth $385,000 after buying an additional 241 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.